权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Oxysterol Regulation of Microbial Pathogenesis

氧甾醇对微生物发病机制的调节

基本信息

批准号：
10592354
负责人：
Neal Mathew Alto
金额：
$ 57.36万
依托单位：
UT SOUTHWESTERN MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-04-01 至 2026-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10592354
关键词：
25-hydroxycholesterol Acute Animals Anti-Bacterial Agents B-Lymphocytes Bacteria Bacterial Infections Biochemical Biochemistry Biological Process Biophysics Biosensor Cell membrane Cell physiology Cell surface Cells Chemicals Cholesterol Cholesterol Homeostasis Circulation Communicable Diseases Cultured Cells Development Distant Drug or chemical Tissue Distribution Endoplasmic Reticulum Epithelial Cells Epithelium Fatty Liver Functional disorder Genetic Glean Goals Gut Mucosa Heart Diseases Homeostasis Human Human Biology Immune Immune system Immunity Immunologics Infection Inflammasome Inflammatory Inflammatory Response Innate Immune Response Intracellular Membranes Lipids Listeria Listeria monocytogenes Listeriosis Macrophage Mammalian Cell Mammals Mediating Membrane Membrane Proteins Membrane Structure and Function Metabolic Pathway Molecular Molecular Probes Monitor Movement Mucosal Immune System Mucous Membrane Mus Natural Immunity Organism Outcome Parasites Pathogenesis Pathogenicity Pathway interactions Penetration Physiological Play Process Production Property Protocols documentation Regulation Regulatory Pathway Resolution Role Shigella Shigella flexneri Signal Pathway Site Surface Surface Tension System Technology Testing Therapeutic Intervention Time Tissues Toxin Viral Virus Visualization Work adaptive immune response biochemical tools cell growth cell motility cell type combat cytokine emerging pathogen gut bacteria gut colonization human pathogen in vivo innovation insight lipid metabolism live cell imaging microbial model organism mouse model new technology novel therapeutics pathogen pathogenic bacteria pathogenic microbe pharmacologic prevent response small molecule transmission process

项目摘要

Project Summary The proposed project focuses on our recent discovery that immunological production of the oxysterol 25- Hydroxycholesterol (25HC) potently inhibits the cellular dissemination of two globally important bacterial pathogens, Listeria monocytogenes and Shigella flexneri. The anti-bacterial activity of 25HC is mediated through mobilization of the accessible cholesterol pool from the plasma membrane (PM). Accessible cholesterol is one of three pools into which PM cholesterol is sub-divided and this pool regulates cellular signaling pathways that control lipid homeostasis and cell growth. By first characterizing the molecular mechanism by which 25HC induces internalization of accessible cholesterol (Aim 1), these studies will reveal how cholesterol can be rapidly transported in response to cytokine stimulation. Second, we will determine how remodeling of PM cholesterol suppresses Listeria and Shigella from penetrating the cell-to-cell contact junctions of the mucosal epithelium (Aim 2). This work will reveal how mammals enhance the barrier function of mucosal surfaces through cholesterol metabolic pathways and will identify points of weakness in the mucosal immune system that may be exploited by numerous microbial pathogens. Third, we will develop new technologies for monitoring cholesterol dynamics in the living organism and use these technologies to determine the tissues and cell types that mobilize accessible cholesterol in response to bacterial infection (Aim 3). Finally, the physiological significance of oxysterol-mediated immune pathways will be investigated in mammalian model organisms using three complementary mouse models that disrupt 25HC activation, production, and downstream activity (Aim 4). Insights gleaned from these studies, which range from basic biochemistry to mouse models of infection, will explain how the human immune system has adapted fundamental aspects of cholesterol metabolism to protect barrier cells from intracellular bacterial infection. Developing new drugs that mimic the molecular activity of 25HC as determined in this proposal would be an innovative approach to combat human infectious disease associated with pathogens that exploit host cholesterol metabolism. These studies will also provide new insights into the pathogenic mechanisms of an important infectious disease-causing agent and also into the biology of the human inflammatory response.

项目总结